Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	75
Overall Study	STARTED	JNJ-42847922 5 mg	72
Overall Study	STARTED	JNJ-42847922 10 mg	74
Overall Study	STARTED	JNJ-42847922 20 mg	71
Overall Study	STARTED	Zolpidem	73
Overall Study	COMPLETED	Placebo	69
Overall Study	COMPLETED	JNJ-42847922 5 mg	68
Overall Study	COMPLETED	JNJ-42847922 10 mg	72
Overall Study	COMPLETED	JNJ-42847922 20 mg	69
Overall Study	COMPLETED	Zolpidem	69
Overall Study	NOT COMPLETED	Placebo	6
Overall Study	NOT COMPLETED	JNJ-42847922 5 mg	4
Overall Study	NOT COMPLETED	JNJ-42847922 10 mg	2
Overall Study	NOT COMPLETED	JNJ-42847922 20 mg	2
Overall Study	NOT COMPLETED	Zolpidem	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03375203/flow